Ascites and epithelial ovarian cancers: a reappraisal with respect to different aspects - PubMed (original) (raw)
Ascites and epithelial ovarian cancers: a reappraisal with respect to different aspects
A Ayhan et al. Int J Gynecol Cancer. 2007 Jan-Feb.
Abstract
Ascites is a common finding in patients with epithelial ovarian cancer (EOC). Clinico-pathologic correlations with respect to the presence of ascites, positive cytology and prognostic role of ascites, and the impact of ascitic volumes were not previously studied extensively. A total of 372 patients with EOC were retrospectively evaluated with respect to presence and amount of ascites, cytologic findings, and survival. Two groups were compared by using Chi-square, Student's t and Mann-Whitney U, binary logistic regression, Kaplan Meier and Cox-regression analysis tests, where appropriate. Omental metastasis (P < 0.001; OR: 3.21, 95% CI = 1.945-5.297) and mean number of metastatic lymph nodes (P= 0.008; OR: 1.063, 95% CI = 1.016-1.112) were significantly related with presence of ascites. Evaluation of ascitic volume at different thresholds revealed lymphatic-omental metastasis, and also the disease stage to be significantly different among patient groups at lower threshold values and the positive cytology and high-grade diseases at higher threshold values. In conclusion, presence of ascites correlates with both the intraperitoneal and also the retroperitoneal tumor spread. Amount of ascites has different correlations with the clinico-pathologic factors depending on the thresholds chosen. At lower volumes, lymphatic and omental metastasis seems to correlate with the development of ascites. Once ascites develops, tumor grade seems to be important for larger ascites volumes. Neither the presence of ascites or its volume nor the cytologic positivity was an independent predictor of survival.
Similar articles
- Metastatic lymph node number in epithelial ovarian carcinoma: does it have any clinical significance?
Ayhan A, Gultekin M, Dursun P, Dogan NU, Aksan G, Guven S, Velipasaoglu M, Yuce K. Ayhan A, et al. Gynecol Oncol. 2008 Feb;108(2):428-32. doi: 10.1016/j.ygyno.2007.09.014. Gynecol Oncol. 2008. PMID: 18249232 - Cytoreductive surgery for stage IV epithelial ovarian cancer.
Zang RY, Zhang ZY, Cai SM, Li ZT, Chen J, Tang MQ, Liu Q. Zang RY, et al. J Exp Clin Cancer Res. 1999 Dec;18(4):449-54. J Exp Clin Cancer Res. 1999. PMID: 10746968 - A large-scale multi-institutional study evaluating prognostic aspects of positive ascites cytology and effects of therapeutic interventions in epithelial ovarian cancer.
Yoshihara M, Emoto R, Kitami K, Iyoshi S, Uno K, Mogi K, Tano S, Yoshikawa N, Matsui S, Kajiyama H. Yoshihara M, et al. Sci Rep. 2021 Jul 26;11(1):15154. doi: 10.1038/s41598-021-93718-3. Sci Rep. 2021. PMID: 34312408 Free PMC article. - Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients.
Zhang Y, Hua W, Niu LC, Li SM, Wang YM, Shang L, Zhang C, Li WN, Wang R, Chen BL, Xin XY, Zhang YQ, Wang J. Zhang Y, et al. Tumour Biol. 2016 Jul;37(7):9423-31. doi: 10.1007/s13277-015-4699-x. Epub 2016 Jan 18. Tumour Biol. 2016. PMID: 26781874
Cited by
- Effect of Intraperitoneal Chemotherapy with Regorafenib on IL-6 and TNF-α Levels and Peritoneal Cytology: Experimental Study in Rats with Colorectal Peritoneal Carcinomatosis.
Bitsianis S, Mantzoros I, Anestiadou E, Christidis P, Chatzakis C, Zapsalis K, Symeonidis S, Ntampakis G, Domvri K, Tsakona A, Bekiari C, Ioannidis O, Aggelopoulos S. Bitsianis S, et al. J Clin Med. 2023 Nov 23;12(23):7267. doi: 10.3390/jcm12237267. J Clin Med. 2023. PMID: 38068319 Free PMC article. - Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers.
Korzun T, Moses AS, Diba P, Sattler AL, Olson B, Taratula OR, Pejovic T, Marks DL, Taratula O. Korzun T, et al. Small. 2024 Oct;20(41):e2301776. doi: 10.1002/smll.202301776. Epub 2023 Jul 30. Small. 2024. PMID: 37518857 Review. - The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination.
Ritch SJ, Telleria CM. Ritch SJ, et al. Front Endocrinol (Lausanne). 2022 Apr 28;13:886533. doi: 10.3389/fendo.2022.886533. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35574025 Free PMC article. Review. - Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response.
Rickard BP, Conrad C, Sorrin AJ, Ruhi MK, Reader JC, Huang SA, Franco W, Scarcelli G, Polacheck WJ, Roque DM, Del Carmen MG, Huang HC, Demirci U, Rizvi I. Rickard BP, et al. Cancers (Basel). 2021 Aug 26;13(17):4318. doi: 10.3390/cancers13174318. Cancers (Basel). 2021. PMID: 34503128 Free PMC article. Review. - Flow-induced Shear Stress Confers Resistance to Carboplatin in an Adherent Three-Dimensional Model for Ovarian Cancer: A Role for EGFR-Targeted Photoimmunotherapy Informed by Physical Stress.
Nath S, Pigula M, Khan AP, Hanna W, Ruhi MK, Dehkordy FM, Pushpavanam K, Rege K, Moore K, Tsujita Y, Conrad C, Inci F, Carmen MGD, Franco W, Celli JP, Demirci U, Hasan T, Huang HC, Rizvi I. Nath S, et al. J Clin Med. 2020 Mar 28;9(4):924. doi: 10.3390/jcm9040924. J Clin Med. 2020. PMID: 32231055 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical